FibroGen Inc. (FGEN)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
3 |
$155,703 |
| Sells |
0 |
$0 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
Open Market Insider Buys
| Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
| 25 Mar 2025 |
WETTIG THANE |
CEO |
24 Mar 2025 |
145,000 |
0.35 |
50,663 |
| 24 Mar 2025 |
SCHOENECK JAMES A |
Director |
21 Mar 2025 |
50,000 |
0.34 |
17,040 |
| 24 Mar 2025 |
SCHOENECK JAMES A |
Director |
20 Mar 2025 |
250,000 |
0.35 |
88,000 |
| 13 Jun 2024 |
ADIB DEYAA |
Chief Medical Officer |
12 Jun 2024 |
22,123 |
1.17 |
25,884 |
| 11 Mar 2024 |
WETTIG THANE |
CEO |
07 Mar 2024 |
50,000 |
1.91 |
95,470 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock